TG Therapeutics | TGTX - DEBITO





DEBITO Cambiamento Data
AbbVie USD 72.86B 5.36B 2026-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Amgen USD 57.32B 2.72B 2026-03
Ardelyx USD 208.26M 653K 2026-03
Arrowhead Research USD 989.46M 676.69M 2026-03
Bayer EUR 36.45B 2.93B 2025-12
Biogen USD 8.09B 1.53B 2026-06
Corcept Therapeutics USD 9.64M 3.53M 2026-03
Curis USD 0 0 2022-06
Gilead Sciences USD 22.17B 2.76B 2026-03
J&J USD 54.99B 7.05B 2026-03
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Novartis USD 49.01B 2.02B 2026-06
Novavax USD 233.31M 4.23M 2024-09
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
TG Therapeutics USD 753.56M 499.85M 2026-03
Verastem USD 66.79M 26.7M 2024-09
Vertex Pharmaceuticals USD 1.99B 44M 2026-03